The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 14, 2010
Filed:
May. 29, 2009
Patrick Bernardelli, Villepreux, FR;
Stefanie Keil, Hofheim, DE;
Matthias Urmann, Eschborn, DE;
Hans Matter, Langenselbold, DE;
Wolfgang Wendler, Selters, DE;
Maike Glien, Wiesbaden, DE;
Karen Chandross, Somerset, NJ (US);
Lan Lee, Pluckemin, NJ (US);
Corinne Terrier, Livry Gargan, FR;
Herve Minoux, Thiais, FR;
Patrick Bernardelli, Villepreux, FR;
Stefanie Keil, Hofheim, DE;
Matthias Urmann, Eschborn, DE;
Hans Matter, Langenselbold, DE;
Wolfgang Wendler, Selters, DE;
Maike Glien, Wiesbaden, DE;
Karen Chandross, Somerset, NJ (US);
Lan Lee, Pluckemin, NJ (US);
Corinne Terrier, Livry Gargan, FR;
Herve Minoux, Thiais, FR;
Sanofi-Aventis, Paris, FR;
Abstract
The invention relates to phenyl-1,2,4-oxadiazolone derivatives with phenyl group and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. What are described are compounds of the formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.